Insider Trading activities at Amgen Inc (AMGN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amgen Inc (AMGN) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amgen Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 318154.

Total stock buying since 2015: $956,734.
Total stock sales since 2015: $90,298,471.
Total stock option exercises since 2015: $38,983,830.


27 insiders reported insider trading activities at Amgen Inc (AMGN):
Insider trading activities of Such Annette Louise
Insider trading activities of Williams R Sanders
Insider trading activities of Graham Jonathan P
Insider trading activities of Harper Sean E
Insider trading activities of Pelham Judith C
Insider trading activities of Tross Stuart A
Insider trading activities of Busch Matthew C.
Insider trading activities of Gordon Murdo
Insider trading activities of Sugar Ronald D
Insider trading activities of Reese David M
Insider trading activities of Bradway Robert A
Insider trading activities of Khosla Rachna
Insider trading activities of Baltimore David
Insider trading activities of Miller Derek
Insider trading activities of Jacks Tyler
Insider trading activities of Santos Esteban
Insider trading activities of Hassan Fred
Insider trading activities of Herringer Frank C
Insider trading activities of Eckert Robert
Insider trading activities of Coffman Vance D
Insider trading activities of Grygiel Nancy A.
Insider trading activities of Henderson Rebecca M
Insider trading activities of Piacquad David
Insider trading activities of Patton Cynthia M
Insider trading activities of Balachandran Madhavan
Insider trading activities of Meline David W
Insider trading activities of De Carbonnel Francois

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Amgen Inc (AMGN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 82,343 $24,445,119 43,991 $6,877,990
2024 0 $0 2,117 $662,800 0 $0
2023 0 $0 21,654 $5,808,720 0 $0
2022 0 $0 15,232 $3,737,768 20,000 $1,711,800
2021 0 $0 18,860 $4,524,885 83,300 $4,910,202
2020 0 $0 15,614 $3,643,574 133,480 $7,780,536
2019 0 $0 52,013 $10,904,941 37,248 $3,835,843
2018 0 $0 32,452 $6,215,128 46,277 $3,114,649
2017 0 $0 15,197 $2,530,027 0 $0
2016 0 $0 78,187 $12,053,770 104,000 $5,351,760
2015 6,010 $956,734 97,389 $15,771,739 120,750 $5,401,050

Table 2. Monthly summary of insider trading at Amgen Inc (AMGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 0 $0 1,267 $376,279 0 $0
2025-05 0 $0 1,000 $279,690 0 $0
2025-02 0 $0 80,076 $23,789,150 43,991 $6,877,990
2024-05 0 $0 2,117 $662,800 0 $0
2023-12 0 $0 2,096 $572,275 0 $0
2023-11 0 $0 10,000 $2,728,140 0 $0
2023-08 0 $0 9,558 $2,508,305 0 $0
2022-11 0 $0 932 $273,328 0 $0
2022-08 0 $0 200 $49,992 20,000 $1,711,800
2022-05 0 $0 14,100 $3,414,448 0 $0
2021-05 0 $0 3,500 $881,862 3,500 $478,140
2021-04 0 $0 1,000 $249,980 1,000 $71,640
2021-03 0 $0 1,000 $231,530 1,000 $71,640
2021-02 0 $0 12,360 $2,925,523 76,800 $4,217,142
2021-01 0 $0 1,000 $235,990 1,000 $71,640
2020-11 0 $0 250 $60,600 0 $0
2020-08 0 $0 1,250 $301,757 1,000 $54,690
2020-07 0 $0 1,000 $259,790 1,000 $54,690
2020-06 0 $0 1,000 $228,540 1,000 $54,690
2020-05 0 $0 1,425 $330,126 1,000 $54,690
2020-04 0 $0 1,000 $233,350 128,000 $7,475,300
2020-03 0 $0 0 $0 1,480 $86,476
2020-02 0 $0 9,689 $2,229,411 0 $0
2019-12 0 $0 0 $0 2,875 $467,475

Table 3. Detailed insider trading at Amgen Inc (AMGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-20 Grygiel Nancy A. (SVP & CCO) Sale 1,267 296.99 376,279
2025-05-02 Busch Matthew C. (VP, Finance & CAO) Sale 1,000 279.69 279,690
2025-02-21 Reese David M (EVP & Chief Technology Officer) Sale 25,225 304.44 7,679,524
2025-02-19 Miller Derek (SVP, Human Resources) Sale 1,524 293.74 447,655
2025-02-19 Miller Derek (SVP, Human Resources) Option Ex 1,524 156.35 238,277
2025-02-19 Reese David M (EVP & Chief Technology Officer) Sale 8,711 293.22 2,554,221
2025-02-19 Reese David M (EVP & Chief Technology Officer) Option Ex 8,711 156.35 1,361,964
2025-02-19 Santos Esteban (EVP, Operations) Sale 8,711 292.84 2,550,903
2025-02-19 Santos Esteban (EVP, Operations) Option Ex 8,711 156.35 1,361,964
2025-02-18 Miller Derek (SVP, Human Resources) Sale 500 292.56 146,279
2025-02-11 Gordon Murdo (EVP, Global Commercial Ops) Sale 8,771 294.80 2,585,646
2025-02-07 Graham Jonathan P (EVP & Gen. Counsel & Secy.) Sale 25,045 293.12 7,341,115
2025-02-07 Graham Jonathan P (EVP & Gen. Counsel & Secy.) Option Ex 25,045 156.35 3,915,785
2025-02-05 Grygiel Nancy A. (SVP & CCO) Sale 1,589 304.47 483,807
2024-05-03 Grygiel Nancy A. (SVP & CCO) Sale 2,117 313.08 662,800
2023-12-04 Grygiel Nancy A. (SVP & CCO) Sale 2,096 273.03 572,275
2023-11-08 Graham Jonathan P (EVP, Gen. Counsel & Secy.) Sale 10,000 272.81 2,728,140
2023-08-10 Gordon Murdo (EVP, Global Commercial Ops) Sale 9,558 262.43 2,508,305
2022-11-09 Khosla Rachna (SVP, Business Development) Sale 387 292.90 113,352
2022-11-08 Grygiel Nancy A. (SVP & CCO) Sale 545 293.54 159,976
2022-08-22 Williams R Sanders (Director) Sale 200 249.96 49,992
2022-08-10 Eckert Robert (Director) Option Ex 20,000 85.59 1,711,800
2022-05-23 Williams R Sanders (Director) Sale 600 250.00 150,000
2022-05-10 Graham Jonathan P (EVP, Gen. Counsel & Secy.) Sale 13,500 241.81 3,264,448
2021-05-12 Sugar Ronald D (Director) Sale 1,000 250.59 250,590
2021-05-12 Sugar Ronald D (Director) Option Ex 1,000 71.64 71,640
2021-05-11 Grygiel Nancy A. (SVP & CCO) Sale 2,500 252.51 631,272
2021-05-11 Grygiel Nancy A. (SVP & CCO) Option Ex 2,500 162.60 406,500
2021-04-14 Sugar Ronald D (Director) Sale 1,000 249.98 249,980
2021-04-14 Sugar Ronald D (Director) Option Ex 1,000 71.64 71,640
2021-03-10 Sugar Ronald D (Director) Sale 1,000 231.53 231,530
2021-03-10 Sugar Ronald D (Director) Option Ex 1,000 71.64 71,640
2021-02-18 Bradway Robert A (Chairman, CEO and President) Option Ex 73,500 54.69 4,019,715
2021-02-16 Reese David M (EVP, Research and Development) Option Ex 2,300 54.69 125,787
2021-02-10 Sugar Ronald D (Director) Sale 1,000 238.40 238,400
2021-02-10 Sugar Ronald D (Director) Option Ex 1,000 71.64 71,640
2021-02-08 Williams R Sanders (Director) Sale 250 237.99 59,497
2021-02-04 Graham Jonathan P (EVP, Gen. Counsel & Secy.) Sale 11,110 236.51 2,627,626
2021-01-13 Sugar Ronald D (Director) Sale 1,000 235.99 235,990
2021-01-13 Sugar Ronald D (Director) Option Ex 1,000 71.64 71,640
2020-11-09 Williams R Sanders (Director) Sale 250 242.40 60,600
2020-08-19 Sugar Ronald D (Director) Sale 1,000 241.02 241,020
2020-08-19 Sugar Ronald D (Director) Option Ex 1,000 54.69 54,690
2020-08-07 Williams R Sanders (Director) Sale 250 242.95 60,737
2020-07-22 Sugar Ronald D (Director) Sale 1,000 259.79 259,790
2020-07-22 Sugar Ronald D (Director) Option Ex 1,000 54.69 54,690
2020-06-17 Sugar Ronald D (Director) Sale 1,000 228.54 228,540
2020-06-17 Sugar Ronald D (Director) Option Ex 1,000 54.69 54,690
2020-05-20 Sugar Ronald D (Director) Sale 1,000 229.27 229,270
2020-05-20 Sugar Ronald D (Director) Option Ex 1,000 54.69 54,690
2020-05-06 Williams R Sanders (Director) Sale 425 237.31 100,856
2020-04-22 Sugar Ronald D (Director) Sale 1,000 233.35 233,350
2020-04-22 Sugar Ronald D (Director) Option Ex 1,000 54.69 54,690
2020-04-13 Bradway Robert A (Chairman, CEO and President) Option Ex 127,000 58.43 7,420,610
2020-03-09 Reese David M (EVP, Research and Development) Option Ex 1,480 58.43 86,476
2020-02-06 Piacquad David (SVP, Business Development) Sale 9,264 229.93 2,130,080
2020-02-06 Williams R Sanders (Director) Sale 425 233.72 99,331
2019-12-13 Piacquad David (SVP, Business Development) Option Ex 2,875 162.60 467,475
2019-11-25 Meline David W (EVP & CFO) Sale 8,737 234.36 2,047,603
2019-11-22 Graham Jonathan P (EVP, Gen. Counsel & Secy.) Sale 9,000 230.54 2,074,833
2019-11-20 Piacquad David (SVP, Business Development) Option Ex 5,749 156.35 898,856
2019-11-06 Williams R Sanders (Director) Sale 425 215.45 91,566
2019-11-06 Sugar Ronald D (Director) Sale 2,000 215.45 430,900
2019-11-06 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-10-02 Sugar Ronald D (Director) Sale 2,000 193.58 387,160
2019-10-02 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-09-04 Sugar Ronald D (Director) Sale 2,000 206.70 413,400
2019-09-04 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-08-30 Patton Cynthia M (SVP & CCO) Sale 13,426 208.07 2,793,507
2019-08-30 Patton Cynthia M (SVP & CCO) Option Ex 8,624 159.47 1,375,312
2019-08-07 Williams R Sanders (Director) Sale 425 183.04 77,792
2019-08-07 Sugar Ronald D (Director) Sale 2,000 183.04 366,080
2019-08-07 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-07-03 Sugar Ronald D (Director) Sale 2,000 187.58 375,160
2019-07-03 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-06-05 Sugar Ronald D (Director) Sale 2,000 175.68 351,360
2019-06-05 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-05-01 Sugar Ronald D (Director) Sale 2,000 175.73 351,460
2019-05-01 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-04-03 Sugar Ronald D (Director) Sale 2,000 193.18 386,360
2019-04-03 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-03-06 Sugar Ronald D (Director) Sale 2,000 188.88 377,760
2019-03-06 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2019-02-07 Sugar Ronald D (Director) Sale 2,000 190.00 380,000
2019-02-07 Sugar Ronald D (Director) Option Ex 2,000 54.71 109,420
2018-12-06 Jacks Tyler (Director) Sale 20,000 195.41 3,908,240
2018-12-06 Jacks Tyler (Director) Option Ex 20,000 82.60 1,652,000
2018-11-30 Piacquad David (SVP, Business Development) Option Ex 6,500 54.69 355,485
2018-11-29 Patton Cynthia M (SVP & CCO) Sale 1,777 202.88 360,519
2018-11-29 Patton Cynthia M (SVP & CCO) Option Ex 1,777 54.69 97,184
2018-08-10 Henderson Rebecca M (Director) Option Ex 3,000 63.11 189,330
2018-07-16 Harper Sean E (EVP, Research & Development) Sale 1,525 195.71 298,457
2018-06-12 Harper Sean E (EVP, Research & Development) Sale 1,525 184.27 281,011
2018-05-14 Harper Sean E (EVP, Research & Development) Sale 1,525 174.10 265,502
2018-05-11 Piacquad David (SVP, Business Development) Option Ex 15,000 54.71 820,650
2018-04-12 Harper Sean E (EVP, Research & Development) Sale 1,525 172.68 263,337
2018-03-16 Harper Sean E (EVP, Research & Development) Sale 1,525 189.75 289,368
2018-02-14 Harper Sean E (EVP, Research & Development) Sale 1,525 174.18 265,624
2018-01-16 Harper Sean E (EVP, Research & Development) Sale 1,525 185.62 283,070
2017-12-12 Harper Sean E (EVP, Research & Development) Sale 1,525 176.83 269,665
2017-11-13 Harper Sean E (EVP, Research & Development) Sale 1,525 171.58 261,659
2017-11-08 De Carbonnel Francois (Director) Sale 4,000 173.61 694,424
2017-10-09 Harper Sean E (EVP, Research & Development) Sale 1,525 185.95 283,573
2017-05-31 Baltimore David (Director) Sale 3,700 153.93 569,541
2017-05-24 Patton Cynthia M (SVP & CCO) Sale 2,922 154.40 451,165
2016-09-09 De Carbonnel Francois (Director) Option Ex 5,000 71.64 358,200
2016-08-02 Such Annette Louise (VP, Finance and CAO) Sale 3,000 174.59 523,758
2016-05-04 Balachandran Madhavan (EVP, Operations) Sale 30,000 154.12 4,623,630
2016-04-29 Harper Sean E (EVP, Research & Development) Sale 21,875 158.00 3,456,140
2016-04-29 Baltimore David (Director) Sale 3,312 157.21 520,682
2016-03-30 Baltimore David (Director) Option Ex 5,000 50.44 252,200
2016-03-14 Herringer Frank C (Director) Option Ex 5,000 50.44 252,200
2016-03-09 Coffman Vance D (Director) Option Ex 5,000 50.44 252,200
2016-03-02 Bradway Robert A (Chairman, CEO and President) Sale 20,000 146.48 2,929,560
2016-03-02 Bradway Robert A (Chairman, CEO and President) Option Ex 84,000 50.44 4,236,960
2015-08-31 De Carbonnel Francois (Director) Sale 5,000 153.84 769,190
2015-08-19 Hassan Fred (Director) Buy 3,010 166.07 499,864
2015-07-31 Pelham Judith C (Director) Sale 5,035 180.40 908,314
2015-06-02 Patton Cynthia M (SVP & CCO) Sale 4,530 157.06 711,481
2015-05-07 Balachandran Madhavan (EVP, Operations) Sale 21,750 157.88 3,433,998
2015-05-07 Balachandran Madhavan (EVP, Operations) Option Ex 21,750 56.56 1,230,180
2015-04-23 Tross Stuart A (SVP, Human Resources) Sale 3,012 169.31 509,964
2015-04-22 Harper Sean E (EVP, Research & Development) Sale 28,000 171.58 4,804,240
2015-03-03 Tross Stuart A (SVP, Human Resources) Sale 4,415 157.74 696,426
2015-03-02 Baltimore David (Director) Sale 3,647 158.76 579,012
2015-02-19 Baltimore David (Director) Option Ex 5,000 42.13 210,650
2015-02-11 Bradway Robert A (Chairman, CEO and President) Sale 22,000 152.69 3,359,114
2015-02-11 Bradway Robert A (Chairman, CEO and President) Option Ex 84,000 42.13 3,538,920
2015-02-06 Coffman Vance D (Director) Option Ex 5,000 42.13 210,650
2015-02-05 Herringer Frank C (Director) Buy 3,000 152.29 456,870
2015-02-05 Herringer Frank C (Director) Option Ex 5,000 42.13 210,650

Insider trading activities including stock purchases, stock sales, and option exercises of AMGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amgen Inc (symbol AMGN, CIK number 318154) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.